New Medication for Moderate to Severe Endometriosis-Associated Pain

What we are studying

The purpose of this research study is to test the safety of the investigational study drug compared to a placebo (an inactive substance) and see what effects (good and bad) it has on patients and their condition.

Who we are studying

Women
Races:
- White
- African American
- Asian
- American Indian or Alaska Native
- Native Hawaiian or Pacific Islander
- Other
All Ethnicities
Ages 18 - 49

Eligibility Criteria

Premenopausal female subjects with moderate to severe endometriosis-associated pain

What is involved

The study will consist of 4 periods: 1) Washout Period if applicable; 2) a Screening Period (up to 75 days before receiving your first dose of study drug); 3) a Treatment Period (6 months or 168 days); 4) a Post-treatment Follow-Up Period if applicable (up to 12 months or 365 days).